The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
COVID
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- COVID-19 (127)
- COVID-19 vaccines (80)
- Advertising (76)
- Prescription medicines (33)
- Regulatory compliance (19)
- Alert/Advisory (15)
- Medicine safety (15)
- Safety (7)
- Disinfectants/Sterilants (6)
- Manufacturing (6)
- In Vitro Diagnostic medical devices (IVDs) (5)
- Labelling and packaging (3)
- Over the counter (OTC) medicines (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Shortages (2)
- Cosmetics (1)
- Import and export (1)
- Listed medicines (1)
- Medicinal cannabis hub (1)
- Non-prescription medicines (1)
- Scheduling (national classification system) (1)
Collection content
307 result(s) found, displaying 291 to 300
-
NoticesInformation on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19
-
Safety alertsAdvice for FMT providers on safety protections related to COVID-19
-
Media releasesThe TGA has issued two infringement notices to Peter Evans' company totalling $25,200 for alleged breaches of therapeutic goods legislation in relation to the promotion of a 'BioCharger' device
-
Media releasesThe TGA has issued infringement notices totalling $25,200 to Queensland company CK Surgitech for alleged breaches relating to COVID-19 test kits
-
Media releasesThe TGA has issued an infringement notice for $12,600 to Labtest Direct for the alleged advertising of COVID-19 Rapid Test kits
-
Media releasesThe TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits
-
NewsThis specification describes the minimal acceptable performance and desired features for a ventilator to be used in Australian hospitals during the current SARS-CoV2 outbreak.
-
Media releasesThe TGA has issued Oxymed Australia Pty Ltd five infringement notices for alleged advertising breaches
-
Safety alertsWe have investigated a report that intravenous high-dose vitamin C may be beneficial in the management of COVID-19
-
Media releasesThe TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19